Posts for keyword:

ipilimumab

Improved PFS with nivo + ipi in patients with advanced NSCLC with high TMB

Patients with newly diagnosed advanced NSCLC with high tumor mutational burden had significantly improved PFS with nivolumab plus ipilimumab.